Night Ambulatory Monitoring Of Blood Pressure (NAMBP)

Insel Gruppe AG, University Hospital Bern

Status: Completed

Conditions: Blood Pressure

Treatments: Device: CSEM Pulse Watch

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT04119518

2016-00614

Details and patient eligibility

About

To determine accuracy of nightly non occlusive blood pressure measurements by the non-occlusive CSEM Pulse Watch compared to a gold standard oscillometric device Spacelabs OnTrak Ambulatory Blood Pressure monitor, Spacelabs Healthcare, Washington, USA) internationally validated for the 24h ABPM in Patients.

Full description

Elevated Blood Pressure (BP) is a chronic medical condition with a prevalence of about 45% in the middle-aged population.

The particular interest of this project is given to the diagnosis and treatment of so-called nocturnal hypertension. Unfortunately, current monitoring practice relies on the use of occlusive pneumatic cuffs inflated around the arm to assess BP. Based on oscillometric technique, occlusive cuffs perform intermittent BP measurements every 20 minutes, thus providing only a limited view of the BP regulation landscape. In addition, oscillometric measurement performs a full occlusion of the measured arm inducing awakening reactions, and leading to non-representative overestimated BP values. The non-occlusive measurement of BP is thus an unsolved problem of modern medicine.

The aim of the NAMBP (Night Ambulatory Monitoring of Blood Pressure) project is to develop, implement and test in clinical trials a first-ever non-occlusive BP sensor to be used during sleep.

A novel technology for the non-occlusive measurement of BP from photoplethysmographic (optical) signals, known as Pulse Wave Analysis (PWA), has been investigated for the past decade by the Centre Suisse d'Electronique et de Microtechnique (CSEM, Neuchâtel, Switzerland). The herein proposed system - the CSEM Pulse Watch - consists in a single sensor (watch-like device) attached at the wrist that measures photoplethysmographic waveforms induced by the pulsatility of the skin arteries of the wrist. These waveforms are then post-processed via PWA: The system will detect features in the measured waveforms that correlate, through the phenomenon of wave reflections, to the underlying BP of the patient.

Enrollment: 70 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients > 18y
• Good understanding of written and oral German
• Signed informed consent
• Scheduled for 24h blood pressure exam

Exclusion criteria

• Patients with unhealthy mental state
• Patients with an active implantable medical device (AIMD)
• Arteriopathy of the upper limbs with/without stenosis
• Severe congestive heart failure (LV-EF ≤25%)
• Sever aortic-valve stenosis mean gradient >40mmHg, valve area <1cm2)
• Congenital heart disease including aortic isthmus stenosis
• Untreated heart rhythm disorders, heart rate at rest > 120/bpm
• Severe untreated arterial hypertension (BPsyst > 180mmHg, BPdiast > 100mmHg)
• Atrial fibrillation
• Instable angina pectoris
• Malcompliance concerning medication intake
• Active alcohol or drug abuse
• Pregnancy or lactation (women of childbearing age will be asked to performed urinary pregnancy test before the screening phase)

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

70 participants in 1 patient group

Healthy and hypertensive subjects

Other group

Description:

Subjects will be enrolled to be monitored for 24 hours via: the non-occlusive CSEM Pulse Watch, and a gold standard oscillometric device (Spacelabs OnTrak Ambulatory Blood Pressure monitor, Spacelabs Healthcare, Washington, USA) internationally validated for the 24h ABPM.

Treatment:

Device: CSEM Pulse Watch